Horner's syndrome (HS) or oculosympathetic paresis consists of the classic triad of unilateral miosis, eyelid ptosis and facial anhydrosis. HS is a condition that is uncommon in paediatric neuro-ophthalmology practice and rarely seen in the paediatric intensive care unit (PICU). Through this review, we hope to increase awareness of the risk factors for this syndrome and ways to possibly prevent it.
DEFINITION
Horner's syndrome was first described in animals in 1852 by French physiologist Claude Bernard. In 1869, a Swiss ophthalmologist named Johann Friedrich Horner was the first to give a complete description of this syndrome in humans 1 . The oculosympathetic palsy appears when the sympathetic innervation of the eye is interrupted by an injury to the neuronal pathway connecting the hypothalamus through the spinal cord to the eye. The pathway consists of three neurons. The first order neuron originates in the posterior-lateral nuclei of the hypothalamus and ends in the spinal cord at the level of T1 (ciliospinal centre of Budge-Waller located between C8 and T2). The second neuron extends from the spinal cord through the stellate ganglion to the superior cervical sympathetic ganglion. The third order neuron extends from this ganglion to innervate the eye and the sweat glands of the lower face 2 .
Mild-to-moderate ptosis (owing to the denervation of the sympathetically controlled upper lid Müller muscle), slight elevation of the lower lid (upside-down ptosis due to the denervation of the lower lid muscle analogous to Müller muscle) and miosis (pupillary dilation after psychosensory stimuli is slower in the affected pupil than in the unaffected pupil) are found in all patients, regardless of the level of the injury. Depending on the level of the lesion, impaired flushing and sweating may be found ipsilaterally. Iris heterochromia (with the affected eye being hypopigmented) is seen in congenital HS 2 .
PHARMACOLOGICAL DIAGNOSIS
The diagnosis of HS is usually made clinically together with possible provocative tests. The cocaine test involves instillation of 4 or 10% liquid cocaine solution into both eyes. After 30 minutes, the healthy pupil dilates maximally while the affected pupil dilates poorly. Cocaine blocks noradrenaline re-uptake in the neuromuscular junction, thus increasing the noradrenaline available to stimulate the iris dilator muscle. In HS the denervated synaptic cleft has little or no noradrenaline. Use of 1% hydroxyamphetamine eye drop solution helps to localise the lesion between the second and third order 
SUMMARY
Horner's syndrome appears when the three-neuron sympathetic pathway is interrupted anywhere from the posterior-lateral nuclei of the hypothalamus through the spinal cord to the eye. In children, Horner's syndrome can be either congenital or acquired, but overall it is a rare finding. There are several causes of Horner's syndrome, some of iatrogenic. Although uncommon in the paediatric population, prompt recognition of the syndrome and immediate treatment may prevent permanent damage to the neuronal pathway. Awareness of the risk of developing iatrogenic Horner's syndrome and early detection of signs are recommended to minimise future disability. neuron lesions 3 . Hydroxyamphetamine stimulates the presynaptic terminal to release noradrenaline, which will cause pupillary dilatation in an intact synapse. If the third order neuron is injured, no pupillary reaction will be seen. In a second order neuron injury, the nerve terminal has degenerated and the pupil will dilate poorly. If only the first order neuron is injured, the second order neuron is intact and hydroxyamphetamine will cause mydriasis 3 .
AETIOLOGY AND PATHOPHYSIOLOGY
Literature review reveals that the aetiology of paediatric HS varies. Generally it is an uncommon finding in paediatrics and rare in the PICU environment. Jeffery et al 1 retrospectively reviewed all HS cases seen in two paediatric ophthalmology clinics in large paediatric referral centres (the Hospital for Sick Children, Toronto, and Wilmer Ophthalmological Institute at The Johns Hopkins University School of Medicine, Baltimore) over ten years. Seventy-three patients met inclusion criteria, 31 (42%) were considered congenital (e.g. birth trauma, congenital varicella), 11 (15%) were acquired without a surgical intervention (e.g. neuroblastoma, trauma and other tumours) and 31 were acquired after surgical intervention (e.g. thoracostomies and thoracotomies). In another large single centre study, Mahoney et al retrospectively reviewed all the paediatric cases seen in a large paediatric neuroophthalmology referral centre (Children's Hospital of Philadelphia) between 1993 and 2005. Overall, 56 cases had been referred during the 12 years of the study. Their findings showed that the aetiology in 28 (50%) of the paediatric Horner's syndrome cases could not be found in spite of an extensive physical exam, laboratory and imaging studies 4 . Tumours, benign and malignant, were considered the largest group of etiologies. In their study, Mahoney et al found 13 (23%) patients to have a neoplasm causing the syndrome. Among these cases, there were five children with neuroblastoma, and one case each of lymphoma, craniopharyngioma, astrocytoma, gliomatosis, medulloepithelioma, neurofibroma, schwannoma and Ewing sarcoma. Sporadic cases of benign tumours, such as reactive cervical lymphadenopathy, juvenile xanthogranulomas and sympathetic paraganglioma were also reported 4, 5 . Trauma and surgical complications are other possible rare causes. Kaya et al 6 prospectively followed 933 adult patients with chest wall intervention (thoracostomy, thoracotomy or thoracic trauma). The chance of developing HS was 1.3%. Five patients with chest tubes developed HS (0.7%). Two paediatric case reports described a similar association between a thoracostomy tube tip placed at the apex of the lung and the development of HS 7, 8 . Paediatric HS after trauma (including traumatic delivery or caesarean section) or surgery were also sporadically reported 4, [9] [10] [11] [12] , all secondary to a direct injury to the three-neuron pathway. various cervical vascular manipulations were reported as causing HS, mainly central venous line placement and access for cardiac catheterisation. Guccione et al reported an incidence of one out of 106 episodes of HS after internal jugular cannulation for cardiac catheterisation in children 13 , Garcia et al reported incidence of one in 66 14 in similar settings. Other case reports 15, 16 describe similar rare findings. The mechanism by which internal jugular vein cannulation may cause HS can be explained by puncture of the vessel causing haemotoma or a direct injury to the neuronal pathway. It is less clear when the procedure was done without complications and there was no evidence of haematoma. Intrapleural infections such as empyema or hydatid cyst were described to be in association with HS cases 17, 18 . Increased intrapleural pressure, as in tension pneumothorax 19, 20 , can irritate the stellate ganglion, while relief of the pressure reversed the HS symptoms. Overall, most investigators suggest that neuropraxia to the second neuron pathway is the most common acquired etiology and is usually multifactorial 21 .
We present an illustration overlying a chest X-ray of a patient with HS previously published by our group 21 . The anatomical location of the second and third neuron pathway and the foreign hardware that was inserted during the PICU admission course are illustrated. The first thoracic (or stellate) ganglion lies in close proximity to the parietal pleura of the lung apex and only a thin layer of connective tissue (the endothoracic fascia) separates these two structures. The great upper body blood vessels, including the internal jugular vein, lie in close proximity to the ganglion. Any process that involves this anatomical space could have caused an injury to the ganglion: inflammation due to infection and empyema, baro/ volume trauma from pneumothorax, a direct injury to the nerve caused by the tip of the chest tube placed at the apex of the thorax or by 'trapping' the ganglion between the jugular catheter and the chest tube, dissection of any of the great head blood vessels, or a haematoma from vascular manipulation during the insertion (including deep injection of local anesthetics 22 ). All have been previously described as possible mechanisms.
OUTCOMES
Some clinical conditions may complicate the ability to diagnose HS in critically ill paediatric patients. An acutely sick child with severe hypoxic respiratory failure is usually heavily sedated and often chemically paralysed. In order to prevent exposure keratitis, thick lubricant ointment is applied to the eyes and the eyelids are either taped shut or a temporary tarsorraphy is done.
Although the natural course of HS is not predictable, there is some evidence that the duration of the injuring process or pressure applied on the second order neuron might be related to the chances of recovery. Kaya et al 6 found an association between the time of repositioning the chest drain and chances of the HS recovery. Four out of five patients, in whom the chest tube was repositioned up to two days after insertion, had a complete resolution of the symptoms within two months, unlike one patient whose tube was removed after three days and had persistent symptoms up to three years 6 .
The diagnosis of HS characteristics is not straightforward, but more likely if suspected. Not recognising the condition might cause permanent disability, and may persist long after the fact that the child's life was saved in the PICU is remembered. This may also have medico-legal implications for the medical team.
The prompt diagnosis and immediate repositioning or removal of any cause may prevent irreversible iatrogenic damage. We recommend daily pupillary size and presence of ptosis evaluation in patients at risk of developing HS (such as the tip of chest tube at the apex of the lung and its proximity to the internal jugular catheter, pneumothorax or empyema drainage) to prevent missing the diagnosis of Horner's syndrome.
